Tellus Pharma Llp

Sells healthcare products, incorporated in 2018 with office in Delhi.

2018 | East Delhi, Delhi (India) | Active
Last Updated: June 15, 2024

Tellus Pharma Llp Profile

Key Indicators

  • Obligation of Contribution ₹ 50.00 K
  • Company Age 6 Year, 8 Months
  • Last Filing with ROC 31 Mar 2023

About Tellus Pharma Llp

Tellus Pharma Llp (TPL) is 6 Year, 8 Months old Limited Liability Partnership 31 May 2018. Its registered office is in East Delhi, Delhi, India.

The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 50.00 K as per MCA.

Company Details

  • Location

    East Delhi, Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN/FCRN

    AAM-7581

  • Incorporation Date

    31 May 2018

  • Date of Accounts and Solvency Statement

    31 Mar 2023

  • ROC Code

    Roc-Delhi

  • Company Classification

    Limited Liability Partnership

Industry

Pharma

Who are the key members and board of directors at Tellus Pharma Llp?

Designated Partners (4)

NameDesignationAppointment DateStatus
Rajeev Sharma Country flag representing In Designated Partner 31-May-2018Current
Jatin Kumar Country flag representing In Designated Partner 31-May-2018Current
Vijendra Nautiyal Country flag representing In Designated Partner 31-May-2018Current
Baljeet Singh Country flag representing In Designated Partner 31-May-2018Current

Financial Performance of Tellus Pharma Llp.

Enhance accessibility to Tellus Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Tellus Pharma Llp?

Unlock access to Tellus Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no Open Charges registered against the LLP as per our records.

How Many Employees Work at Tellus Pharma Llp?

Unlock and access historical data on people associated with Tellus Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Tellus Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tellus Pharma Llp's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Tellus Pharma Llp

Recent activity within the organization

  • Statement of Assets & Liabilities

    Tellus Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with RoC-Delhi.

    31 Mar 2023

  • Director Appointment

    Rajeev Sharma was appointed as a Designated Partner was appointed as a Designated Partner on 31 May 2018 & has been associated with this company since 6 years 8 months .

    31 May 2018

  • Director Appointment

    Jatin Kumar was appointed as a Designated Partner was appointed as a Designated Partner on 31 May 2018 & has been associated with this company since 6 years 8 months .

    31 May 2018

  • Director Appointment

    Vijendra Nautiyal was appointed as a Designated Partner was appointed as a Designated Partner on 31 May 2018 & has been associated with this company since 6 years 8 months .

    31 May 2018

  • Director Appointment

    Baljeet Singh was appointed as a Designated Partner was appointed as a Designated Partner on 31 May 2018 & has been associated with this company since 6 years 8 months .

    31 May 2018

  • LLP Incorporation

    Tellus Pharma Llp was registered on 31 May 2018 with RoC-Delhi & aged 6 years 8 months as per MCA records.

    31 May 2018

Frequently asked questions

  • Tellus Pharma Llp was incorporated on 31 May 2018.

  • The Obligation of Contribution of Tellus Pharma Llp is ₹ 50.00 K .

  • Currently 4 partners are associated with Tellus Pharma Llp.

    • Rajeev Sharma
    • Jatin Kumar
    • Vijendra Nautiyal
    • Baljeet Singh
    Rajeev SharmaJatin KumarVijendra NautiyalBaljeet Singh
  • As per Ministry of Corporate Affairs (Mca), the registered address of Tellus Pharma Llp is A-1/157/158 Main Road Shakarpur Extention Na Laxmi Nagar, East Delhi, India, 110092.

  • The Limited Liability Partnership Identification Number (LLPIN) of Tellus Pharma Llp is AAM-7581.

  • The most recent Balance Sheet for Tellus Pharma Llp was filed with the ROC on 31 Mar 2023.